New gene identified in development of fat cells
Research from the University of Central Florida indentifies a gene that controls the development of fat cells. Monocyte Chemotactic Protein-1 Induced Protein (MCPIP) gives scientists a new direction for developing drugs that would prevent the body from becoming resistant to insulin and prone to type 2 diabetes.
MCPIP is a regulator of fat cell formation and blood vessel formation that feeds growing fat tissue. Predominance of fatty tissue contributes to the inability to process insulin, potentially triggering type 2 diabetes. Until recently, a different protein, known as peroxisome proliferator-activated receptor gamma (PPAR gamma) was thought to be the the master controller of fat cell formation.
The creation of new drugs that can block or slow down the formation of MCPIP has the potential to help hundreds of millions of people worldwide who are clinically obese and to dramatically reduce health care costs. Establishing chemical combinations effective at shutting down MCPIP will likely take several years, but researchers are encouraged by recent results.
News source: http://www.sciencedaily.com/releases/2009/08/090826110112.htm
Health Headlines
upcoming Events
U.S. Events
congresses
fellowships
-
Aesthetic Medicine Module I
Las Vegas, NV | Dec. 9-10, 2009 -
Anti-Aging & Regenerative Medicine Modules I, II, III & IX
Las Vegas, NV | Dec. 10-12, 2009 -
Preventative Medicine, Nutrition & Sports Medicine Module I
Las Vegas, NV | Dec. 9-11, 2009 -
Fellowship in Preventative Medicine, Nutrition & Sports Medicine Module III
Las Vegas, NV | Dec. 11-12, 2009
symposium
-
Advanced Hormone Symposium
Chicago, IL | Oct. 8-10, 2010
VIDEO: Brain Age Workshop
Dr. Eric Braverman, Director of The Place for Achieving Total Health
(PATH Medical), Chairs the
Brain Age Workshop taking place Dec. 9, 2009.
Held in conjunction with the Winter Session of the 17th Annual World
Congress on Anti-Aging Medicine & Regenerative Biomedical Technologies.
The Brain Age Workshop features presentations on Brain Mind Assessment
via Neuropsychological Analysis, Movement Deficiency Syndrome,
Hormones and the Brain, Nootropic Drug Mechanisms, and Traumatic Brain
Injury. View this video to learn about Dr. Braverman’s brain-based
model of aging and age modulation.
International Events
- Mexico City | Jan. 15-17, 2010
- Milan | Mar. 18-20, 2010
- Kuala Lumpur | Apr. 29 - May 2, 2010
- Jakarta | May 2010 (pending)
- Bucharest | May 2010 (pending)
- Seoul | May 2010 (pending)
- Melbourne | Aug. 21-22, 2010
- Dubai | Oct. 26-27, 2010
- Bali | October 2010 (pending)
- Mainz-Frankfurt | Nov. 8-10, 2010
- Sao Paulo | Nov. 12-14, 2010
- Shanghai | November 2010 (pending)





